Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
May
10
2021
Waiver Of Intellectual Property Protections For COVID-19 Vaccine Unlikely To Have Meaningful Impact In Short Term Sheppard, Mullin, Richter & Hampton LLP
May
10
2021
The American Families Plan & A Call for Drug Pricing Legislation Mintz
May
10
2021
FDA Notice Concerning “Healthy” Symbol Keller and Heckman LLP
May
10
2021
CNIL Issues Provisional Recommendations for Remote Quality Control of Clinical Trials During the Health Crisis McDermott Will & Emery
May
10
2021
Alabama Legislature Approves Medical Marijuana: Roll Tide! (and a Joint?) Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
May
8
2021
FDA Proposes Risk-Based and Remote Inspection Strategies in New Report Sheppard, Mullin, Richter & Hampton LLP
May
7
2021
FDA Releases Forward-Looking Report on Inspections Keller and Heckman LLP
May
7
2021
Court Issues a Rare, Severe Discovery Sanction: The Path that Led to Default Judgment Nelson Mullins
May
7
2021
EC Review of Its Recommendation on the Definition of Nanomaterial Includes Targeted Stakeholder Consultation Bergeson & Campbell, P.C.
May
7
2021
Clinical Trials: Does FDA’s Notice to Acceleron Signal a New Era of Enforcement for Results Reporting? Foley & Lardner LLP
May
7
2021
HHS Exemptions for Buprenorphine (But not Methadone) Prescribers K&L Gates
May
7
2021
Brexit and food additive authorisation procedures Keller and Heckman LLP
May
6
2021
In Historic Vote, Alabama House of Representatives Passes Medical Cannabis Bill Bradley Arant Boult Cummings LLP
May
6
2021
Girl Scout Troop Teams Up with Wing for Drone Cookie Deliveries Robinson & Cole LLP
May
6
2021
EFSA Finds Titanium Dioxide is Not Safe for Food Keller and Heckman LLP
May
6
2021
FDA Ups the Ante and Sends First Notice of Noncompliance for Failure to Submit Clinical Trial Results Mintz
May
6
2021
Philadelphia Will Ban Pre-Employment Marijuana Testing in 2022 Jackson Lewis P.C.
May
6
2021
EC To Hold Webinar On Biotechnology IP Bergeson & Campbell, P.C.
May
5
2021
California Court Upholds Employer’s Refusal To Hire Applicant Who Failed Pre-Employment Drug Test Due To Medical Marijuana Use Jackson Lewis P.C.
May
5
2021
FDA Issues Two Warning Letters for Undeclared Allergens Keller and Heckman LLP
May
4
2021
EFSA’s Updated Administrative Guidance on Food-Contact Materials Subject to Authorizations Now in Effect Keller and Heckman LLP
May
3
2021
FDA Adds Eight New Substances to its Inventory of Effective FCS Notifications - May 2021 Keller and Heckman LLP
May
3
2021
NY Attorney General Probes Arsenic in Baby Cereal Keller and Heckman LLP
May
3
2021
New York Amends its Off-Duty Conduct Law to Account for Marijuana Use Mintz
May
1
2021
Marijuana Laws Affecting the Workplace: Tools Employers Can Use to Stay Ahead During High Times Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
30
2021
New York State Legalizes Recreational Marijuana: What Employers Need to Know Sheppard, Mullin, Richter & Hampton LLP
Apr
30
2021
EU Considers Benefits of New Genomic Techniques Keller and Heckman LLP
Apr
30
2021
EPA Announces Updates to Confidential Status of Chemicals on the TSCA Inventory Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins